🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to compare the effect of mitapivat v...
Status
Recruiting
Location
Weill Cornell Medical College/ New York Presbyterian
Start Date
2026-09
Trial ID
NCT07506863
Treatments Being Tested
The primary objective of this study was to compare the effect of mitapivat ...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2021-11-30
Trial ID
NCT04770779
Treatments Being Tested
The primary purpose of this study was to compare the effect of mitapivat ve...
Status
Active Not Recruiting
Location
San Diego Hospital, UC San Diego Health
Start Date
2021-12-20
Trial ID
NCT04770753
Treatments Being Tested
This clinical trial is a Phase 2/3 study that will determine the recommende...
Status
Active Not Recruiting
Location
University of California San Diego
Start Date
2022-02-11
Trial ID
NCT05031780
Treatments Being Tested
The primary objective of this study is to compare the effect of mitapivat v...
Status
Recruiting
Location
Stanford Medicine
Start Date
2026-09
Trial ID
NCT07517133
Treatments Being Tested
The primary objective of this study is to determine the effect of mitapivat...
Status
Recruiting
Location
Indiana Hemophilia & Thrombosis Center
Start Date
2026-07-21
Trial ID
NCT07656415
Treatments Being Tested
Study AG348-C-006 evaluated the efficacy and safety of orally administered ...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2018-08-09
Trial ID
NCT03548220
ACTIVATE-KidsT (AG348-C-022) is a multicenter study designed to evaluate th...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2022-06-08
Trial ID
NCT05144256
Treatments Being Tested
Study ACTIVATE-Kids (AG348-C-023) will evaluate the efficacy and safety of ...
Status
Active Not Recruiting
Location
Stanford Medicine
Start Date
2022-06-06
Trial ID
NCT05175105
Treatments Being Tested
This is a Phase 1, randomized, single-dose, double-blinded, 4-period, cross...
Status
Completed
Location
PPD Development, LP
Start Date
2020-06-17
Trial ID
NCT04472832